Patents by Inventor David Barrios

David Barrios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR EVALUATION OF ANTIPLATELET DRUG SENSITIVITY
    Publication number: 20250189545
    Abstract: In some aspects, the disclosure relates to compositions and methods for detecting phosphorylation of dynamin-related protein 1 (Drp1) at position Ser-616. In some embodiments, methods described by the disclosure are useful for detecting antiplatelet agent sensitivity in a subject. In some embodiments, methods described by the disclosure are useful for detecting if a subject has been previously exposed to an antiplatelet agent.
    Type: Application
    Filed: January 17, 2025
    Publication date: June 12, 2025
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Robert Flaumenhaft, David Barrios, Secil Koseoglu
  • Compositions and methods for evaluation of antiplatelet drug sensitivity
    Patent number: 12235278
    Abstract: In some aspects, the disclosure relates to compositions and methods for detecting phosphorylation of dynamin-related protein 1 (Dip1) at position Ser-616. In some embodiments, methods described by the disclosure are useful for detecting antiplatelet agent sensitivity in a subject. In some embodiments, methods described by the disclosure are useful for detecting if a subject has been previously exposed to an antiplatelet agent.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: February 25, 2025
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Robert Flaumenhaft, David Barrios, Secil Koseoglu
  • COMPOSITIONS AND METHODS FOR EVALUATION OF ANTIPLATELET DRUG SENSITIVITY
    Publication number: 20210181214
    Abstract: In some aspects, the disclosure relates to compositions and methods for detecting phosphorylation of dynamin-related protein 1 (Dip1) at position Ser-616. In some embodiments, methods described by the disclosure are useful for detecting antiplatelet agent sensitivity in a subject. In some embodiments, methods described by the disclosure are useful for detecting if a subject has been previously exposed to an antiplatelet agent.
    Type: Application
    Filed: August 23, 2019
    Publication date: June 17, 2021
    Applicant: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Robert Flaumenhaft, David Barrios, Secil Koseoglu